Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | -23.92 | -35.05 | 31.87 | 61.04 | -86.36 |
EBIT | -23.92 | -35.05 | 31.87 | 61.04 | -86.36 |
Other financial income | 0.07 | 0.01 | |||
Other financial expenses | -15.68 | -21.04 | -22.68 | -25.15 | -30.05 |
Pre-tax profit | -39.60 | -56.02 | 9.19 | 35.91 | - 116.42 |
Net earnings | -39.60 | -56.02 | 9.19 | 35.91 | - 116.42 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Tangible assets total | |||||
Investments total | |||||
Long term receivables total | |||||
Finished products/goods | 280.17 | 437.65 | 353.94 | 43.07 | 256.69 |
Inventories total | 280.17 | 437.65 | 353.94 | 43.07 | 256.69 |
Short term receivables total | |||||
Other current investments | 0.26 | 0.15 | 0.14 | 0.14 | 0.10 |
Cash and bank deposits | 42.55 | 5.92 | 154.13 | 216.16 | 21.35 |
Cash and cash equivalents | 42.81 | 6.08 | 154.27 | 216.30 | 21.45 |
Balance sheet total (assets) | 322.98 | 443.73 | 508.21 | 259.37 | 278.14 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
Retained earnings | - 505.10 | - 544.70 | - 600.72 | - 591.53 | - 555.62 |
Profit of the financial year | -39.60 | -56.02 | 9.19 | 35.91 | - 116.42 |
Shareholders equity total | - 419.70 | - 475.72 | - 466.53 | - 430.62 | - 547.04 |
Non-current liabilities total | |||||
Current trade creditors | 20.00 | 20.00 | 20.00 | 21.20 | 21.90 |
Current owed to group member | 658.83 | 854.68 | 901.67 | 625.91 | 780.95 |
Other non-interest bearing current liabilities | 63.85 | 44.77 | 53.07 | 42.88 | 22.33 |
Current liabilities total | 742.68 | 919.45 | 974.74 | 689.99 | 825.18 |
Balance sheet total (liabilities) | 322.98 | 443.73 | 508.21 | 259.37 | 278.14 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.